21st Century Oncology Inc:企業の戦略的SWOT分析

◆英語タイトル:21st Century Oncology Inc - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2874
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

21st Century Oncology Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

21st Century Oncology Inc (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services. It provides radiation therapy and integrated cancer care services to patients. The company has affiliations with physicians specializing in the areas of medical oncology, urology, gynecological, breast and surgical oncology, general surgery, radiation oncology, and primary care. It also offers specialized delivery systems for internal beam radiation therapy. The company operates through international treatment centers operations in the US and in certain Latin American markets. 21st Century Oncology is headquartered in Fort Myers, Florida, the US.

21st Century Oncology Inc Key Recent Developments

Feb 26,2020: Dr. Sonal Sura joins 21st Century Oncology’s Naples And Bonita Springs office locations
May 28,2019: 21st Century Oncology appoints Dr. Mohammad Jahanzeb to Chief Medical Oncology Scientific And Strategic Advisor
Apr 10,2019: 21st Century Oncology’s Vladimir Ioffe, MD urges for more prostate cancer screenings despite government’s view that ‘it’s unnecessary’
Mar 14,2019: 21st Century Oncology bolsters its best-in-class Oncology dream team by adding five nationally renowned physicians
Jan 07,2019: 21st Century Oncology hires Powell as chief operating officer

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
21st Century Oncology Inc – Key Facts
21st Century Oncology Inc – Key Employees
21st Century Oncology Inc – Key Employee Biographies
21st Century Oncology Inc – Major Products and Services
21st Century Oncology Inc – History
21st Century Oncology Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
21st Century Oncology Inc – Business Description
21st Century Oncology Inc – SWOT Analysis
SWOT Analysis – Overview
21st Century Oncology Inc – Strengths
21st Century Oncology Inc – Weaknesses
21st Century Oncology Inc – Opportunities
21st Century Oncology Inc – Threats
21st Century Oncology Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
21st Century Oncology Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 26, 2020: Dr. Sonal Sura joins 21st Century Oncology’s Naples And Bonita Springs office locations
May 28, 2019: 21st Century Oncology appoints Dr. Mohammad Jahanzeb to Chief Medical Oncology Scientific And Strategic Advisor
Apr 10, 2019: 21st Century Oncology’s Vladimir Ioffe, MD urges for more prostate cancer screenings despite government’s view that ‘it’s unnecessary’
Mar 14, 2019: 21st Century Oncology bolsters its best-in-class Oncology dream team by adding five nationally renowned physicians
Jan 07, 2019: 21st Century Oncology hires Powell as chief operating officer
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
21st Century Oncology Inc, Key Facts
21st Century Oncology Inc, Key Employees
21st Century Oncology Inc, Key Employee Biographies
21st Century Oncology Inc, Major Products and Services
21st Century Oncology Inc, History
21st Century Oncology Inc, Other Locations
21st Century Oncology Inc, Subsidiaries
21st Century Oncology Inc, Key Competitors
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
21st Century Oncology Inc, Recent Deals Summary

List of Figures
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[21st Century Oncology Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meiji Holdings Co, Ltd.:企業の戦略・SWOT・財務情報
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • gel-e Inc:製品パイプライン分析
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc is a medical device company that offers products for the treatment of acute wounds. The company's products include spray foams, bandages, gels, films, and band-aids. It offers proprietary technology platform that helps in development of w …
  • Tokmanni Group Oyj (TOKMAN):企業の財務・戦略的SWOT分析
    Tokmanni Group Oyj (TOKMAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Alleghany Corporation:戦略・SWOT・企業財務分析
    Alleghany Corporation - Strategy, SWOT and Corporate Finance Report Summary Alleghany Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ebara Corporation:企業の戦略・SWOT・財務分析
    Ebara Corporation - Strategy, SWOT and Corporate Finance Report Summary Ebara Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Carpenter Co.:企業の戦略・SWOT・財務情報
    Carpenter Co. - Strategy, SWOT and Corporate Finance Report Summary Carpenter Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sysmex Corp (6869):企業の製品パイプライン分析2018
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Telia Company AB:企業の戦略・SWOT・財務分析
    Telia Company AB - Strategy, SWOT and Corporate Finance Report Summary Telia Company AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Depository Trust & Clearing Corporation:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Paychex, Inc. (PAYX):企業の財務・戦略的SWOT分析
    Paychex, Inc. (PAYX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pioneer Natural Resources Company:企業のM&A・事業提携・投資動向
    Pioneer Natural Resources Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pioneer Natural Resources Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Aurora Health Care Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aurora Health Care Inc (AHC) is an integrated, not-for-profit, health care system that provides inpatient and outpatient health care in the State of Wisconsin. The organization offers its healthcare services to communities throughout eastern Wisconsin, northern Illinois and the upper peninsu …
  • Human Stem Cells Institute (ISKJ):企業の財務・戦略的SWOT分析
    Summary Human Stem Cells Institute (HSCI) is a biotech company that provides discovery, research and development, and marketing of proprietary products and services in the areas of regenerative medicine, medical genetics, bio-insurance, gene therapy and biopharmaceutics. The company offers neovascul …
  • Celixir Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Celixir Ltd (CTL), formerly Cell Therapy Ltd is a biotechnology company that discovers and develops regenerative medicines using adult stem cells for the treatment of heart failure. The company provids heartcel which is a type of stem cell therapy that provides improved outcomes for end-stag …
  • Horizon Oil Ltd (HZN):企業の財務・戦略的SWOT分析
    Summary Horizon Oil Ltd (Horizon) is an oil and gas exploration and production company that acquires, explores, develops and produces oil and petroleum properties. The company holds interests in Maari and Manaia fields located in the Taranaki Basin approximately 80 kilometre offshore the north islan …
  • Mytilineos Holdings Sa:企業の戦略・SWOT・財務分析
    Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report Summary Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lloyds Banking Group Plc:企業の戦略・SWOT・財務情報
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vascular Biogenics Ltd (VBLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for ca …
  • Transmetro Corporation Limited:企業の戦略・SWOT・財務分析
    Transmetro Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Transmetro Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆